Indication
EoE
2 clinical trials
2 products
Clinical trial
Dupilumab for Eosinophilic Esophagitis With Severe Strictures (DESTRICT Study)Status: Not yet recruiting, Estimated PCD: 2025-11-01
Product
DupilumabClinical trial
A Multi-center, Randomized, Double Blind, Parallel-arm, Placebo Controlled Trial of Mepolizumab for Treatment of Adults and Adolescents With Active Eosinophilic Esophagitis and Dysphagia-predominant SymptomsStatus: Completed, Estimated PCD: 2022-06-06
Product
Mepolizumab